ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

K-LYTE/CL 50
Electrolyte disturbances
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

K-LYTE/CL 50 Rx

Generic Name and Formulations:
Potassium (as chloride) 50mEq; effervescent tabs for soln; citrus and fruit-flavor.

Company:
Bristol-Myers Squibb

Therapeutic Use:

Indications for K-LYTE/CL 50:

Hypokalemia, including that caused by diuretics. Digitalis intoxication without AV block.

Adult:

Prophylaxis: 25mEq daily. Treatment: 50–100mEq daily in divided doses. Both, dissolve each tab in 6–8oz of water and sip slowly over 5–10 minutes after meals.

Children:

Not recommended.

Contraindications:

Hyperkalemia. Chronic renal disease. Acute dehydration. Heat cramps. Severe tissue destruction. Adrenal insufficiency. Familial periodic paralysis. Acidosis (potassium chloride products). Alkalosis (potassium bicarbonate products). Tablets: Esophageal compression due to enlarged left atrium. Decreased GI motility.

Warnings/Precautions:

Discontinue if GI bleed, ulceration, or other disturbances occur. Renal or cardiac disease. Monitor potassium level, clinical status, acid-base balance, and ECG. Elderly. Pregnancy (Cat.C). Nursing mothers.

Interactions:

Hyperkalemia with ACE inhibitors, spironolactone, triamterene, amiloride, and potassium-containing salt substitutes. Anticholinergics, other agents that decrease GI motility increase risk of serious GI reactions with tablets.

See Also:

K-LYTE/CL

Adverse Reactions:

Hyperkalemia, GI discomfort and irritation, diarrhea, rash (rare). Tablets: Esophageal and GI ulceration, bleeding, obstruction, perforation.

How Supplied:

K-Lyte/Cl tabs—30, 100, 250; K-Lyte/Cl 50 tabs—30, 100

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs